Literature DB >> 25651217

Myelopathy due to degenerative and structural spine diseases.

Jinny O Tavee, Kerry H Levin.   

Abstract

PURPOSE OF REVIEW: This article reviews the current evaluation and treatment of patients with myelopathy due to cervical spondylotic disease and other structural disorders of the spine. RECENT
FINDINGS: In patients with cervical spondylotic myelopathy, symptom duration, severity at baseline, and possibly age have been identified as key prognostic markers of clinical course and postsurgical outcome. Other potential markers include specific MRI and EMG findings. The diagnosis and monitoring of syringomyelia is enhanced by the addition of phase contrast MRI, which evaluates CSF flow dynamics. Flexion MRI is helpful in establishing the diagnosis of Hirayama disease, which is now attributed to a tightened dural sac that is displaced anteriorly on neck flexion, compressing the cord.
SUMMARY: Advances in neuroimaging along with new insights into the pathophysiology of structural spine diseases can help guide clinical decision making and optimize patient outcomes.

Entities:  

Mesh:

Year:  2015        PMID: 25651217     DOI: 10.1212/01.CON.0000461084.71618.35

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  2 in total

1.  Cervical Flexion Myelopathy Eleven Years after a Cervical Spinal Cord Injury.

Authors:  Hiroto Nakano; Kenji Sakai; Kazuo Iwasa; Masahito Yamada
Journal:  Intern Med       Date:  2017-08-01       Impact factor: 1.271

2.  MRI findings in cervical spondylotic myelopathy with gadolinium enhancement: Review of seven cases.

Authors:  Lucas María Pessini Ferreira; Cristina Auger; Izaro Kortazar Zubizarreta; Gonzalo Gonzalez Chinchon; Isabel Herrera; Albert Pla; Andrea de Barros; Carlos Tortajada; Alex Rovira
Journal:  BJR Case Rep       Date:  2021-01-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.